Literature DB >> 35991473

Striving toward hepatitis C elimination in the era of COVID-19.

Charlotte Lanièce Delaunay1,2, Zoë R Greenwald3, Nanor Minoyan4,5, Andreea Adelina Artenie6, Dahn Jeong7,8, Gayatri Marathe1,2, Yasmin A Saeed9, Gillian Kolla10, Rasika D Kunden11, Chisom Ifeoma Adaeze Okwor12, Hannah L Wallace13, Andrew Mendlowitz14,15, Ching-Hsuan Liu16,17, Sabrina Mazouz18, Simmone D'souza19, Catia Taniela Perciani20, Marylin Rheault21, Michael A Palmer11, Adam Palayew22, Mohamed N Abdelnabi4, Evan B Cunningham23.   

Abstract

Entities:  

Keywords:  COVID-19; SARS-CoV-2; hepatitis C elimination; people who use drugs Author Affiliation ; priority populations

Year:  2021        PMID: 35991473      PMCID: PMC9203169          DOI: 10.3138/canlivj-2020-0027

Source DB:  PubMed          Journal:  Can Liver J        ISSN: 2561-4444


× No keyword cloud information.
  15 in total

1.  Covid-19: Risk of second wave is very real, say researchers.

Authors:  Jacqui Wise
Journal:  BMJ       Date:  2020-06-09

2.  Global timing of hepatitis C virus elimination in high-income countries.

Authors:  Homie Razavi; Yuri Sanchez Gonzalez; Cammy Yuen; Markus Cornberg
Journal:  Liver Int       Date:  2019-12-23       Impact factor: 5.828

3.  Signal of increased opioid overdose during COVID-19 from emergency medical services data.

Authors:  Svetla Slavova; Peter Rock; Heather M Bush; Dana Quesinberry; Sharon L Walsh
Journal:  Drug Alcohol Depend       Date:  2020-07-10       Impact factor: 4.492

4.  Potential Influences of the COVID-19 Pandemic on Drug Use and HIV Care Among People Living with HIV and Substance Use Disorders: Experience from a Pilot mHealth Intervention.

Authors:  Karli R Hochstatter; Wajiha Z Akhtar; Sarah Dietz; Klaren Pe-Romashko; David H Gustafson; Dhavan V Shah; Sarah Krechel; Cameron Liebert; Rebecca Miller; Nabila El-Bassel; Ryan P Westergaard
Journal:  AIDS Behav       Date:  2021-02

5.  Telemedicine in Liver Disease and Beyond: Can the COVID-19 Crisis Lead to Action?

Authors:  Marina Serper; Allen W Cubell; Mary Elisabeth Deleener; Tara K Casher; Dale J Rosenberg; Dale Whitebloom; Roy M Rosin
Journal:  Hepatology       Date:  2020-08       Impact factor: 17.425

6.  Syringe services program (SSP) operational changes during the COVID-19 global outbreak.

Authors:  Tyler S Bartholomew; Nobuyo Nakamura; Lisa R Metsch; Hansel E Tookes
Journal:  Int J Drug Policy       Date:  2020-06-12

7.  Safer opioid distribution in response to the COVID-19 pandemic.

Authors:  Mark Tyndall
Journal:  Int J Drug Policy       Date:  2020-07-27

8.  COVID-19 - Enacting a 'new normal' for people who use drugs.

Authors:  Judy Chang; Jake Agliata; Mauro Guarinieri
Journal:  Int J Drug Policy       Date:  2020-07-03

9.  Assessment of Treatment Strategies to Achieve Hepatitis C Elimination in Canada Using a Validated Model.

Authors:  Mawuena Binka; Naveed Z Janjua; Jason Grebely; Chris Estes; Dena Schanzer; Jisoo A Kwon; Naglaa H Shoukry; Jeffrey C Kwong; Homie Razavi; Jordan J Feld; Mel Krajden
Journal:  JAMA Netw Open       Date:  2020-05-01

10.  The Impact of COVID-19 on Syringe Services Programs in the United States.

Authors:  Sara N Glick; Stephanie M Prohaska; Paul A LaKosky; Alexa M Juarez; Maria A Corcorran; Don C Des Jarlais
Journal:  AIDS Behav       Date:  2020-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.